Researchers uncover the source of diabetic nerve pain

Researchers uncover the source of diabetic pain
The image on the left shows nerve fibres (green) in a normal mouse, while the loss of nerve fibres in a diabetic mouse is clearly visible in the image on the right. Human diabetic patients show a similar loss of nerve fibres and the activity of HCN2 in these fibres is associated with the development of pain. Credit: King's College London

A new King's College London study reveals the molecular basis of chronic nerve pain in diabetes. The findings in mice, published today in Science Translational Medicine, could one day lead to treatments which target the source of the pain.

Around one in four people with diabetes develop a condition induced by damage, called painful diabetic neuropathy (PDN), due to . Symptoms include prickling and tingling sensations as well as sharp, shooting pains and extreme sensitivity to touch in the feet and hands, which can spread upward into the legs and arms. The pain can significantly impair mobility, which in turn exacerbates obesity and worsens type 2 diabetes in a self-perpetuating cycle.

Diabetic pain is very difficult to treat and the molecular causes are poorly understood. This new King's College London study provides the first evidence that a single protein molecule - HCN2 - can by itself be responsible for a complex sensation such as diabetic pain.

The researchers used mouse models of diabetes to show that over-activity of HCN2, which initiates electrical signals in pain-sensitive nerve fibres, results in a sensation of pain. They also found that blocking the activity of HCN2, or removing it completely from pain-sensitive nerve fibres, stopped the sensation of pain entirely.

Professor Peter McNaughton, senior author of the study, from the Wolfson Centre for Age-Related Diseases at King's College London, said: "The inexorable rise of obesity worldwide, in both rich and poorer countries, has brought a related increase in type 2 diabetes. As many as one in four diabetics suffer from nerve pain, yet there are currently no effective treatments and people therefore typically must resign themselves to a life of continuous suffering.

"Our study reveals the molecular mechanism driving diabetic pain in mice, which we hope will inform future treatments in people with ."

Dr Christoforos Tsantoulas, first author of the study, also from the Wolfson Centre for Age-Related Diseases at King's College London, said: "At present we do not have selective drugs which can suppress the activity of HCN2 without affecting other bodily functions, such as the regulation of heart rate. This research provides a stimulus for the development of targeted drugs that can block HCN2 without affecting the activity of other molecules."


Explore further

Chronic pain gene identified

More information: C.T. Tsantoulas el al., "Hyperpolarization-activated cyclic nucleotide–gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aam6072
Journal information: Science Translational Medicine

Citation: Researchers uncover the source of diabetic nerve pain (2017, September 27) retrieved 23 April 2019 from https://medicalxpress.com/news/2017-09-uncover-source-diabetic-nerve-pain.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1814 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more